Highlights

array(40) {
  [0]=>
  string(4) "2479"
  ["article_id"]=>
  string(4) "2479"
  [1]=>
  string(105) "Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain"
  ["article_title"]=>
  string(105) "Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Postoperative Pain"
  [2]=>
  string(150) "SAN DIEGO, May 1, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the live"
  ["short_description"]=>
  string(150) "SAN DIEGO, May 1, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the live"
  [3]=>
  string(249) "SAN DIEGO, May 1, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet..."
  ["description"]=>
  string(249) "SAN DIEGO, May 1, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "9"
  ["rss_id"]=>
  string(1) "9"
  [14]=>
  string(194) "https://www.drugs.com/nda/htx_011_190501.html?utm_source=ddc&utm_medium=rss&utm_campaign=Heron+Therapeutics+Receives+Complete+Response+Letter+For+HTX-011+For+The+Management+Of+Postoperative+Pain"
  ["blog_url"]=>
  string(194) "https://www.drugs.com/nda/htx_011_190501.html?utm_source=ddc&utm_medium=rss&utm_campaign=Heron+Therapeutics+Receives+Complete+Response+Letter+For+HTX-011+For+The+Management+Of+Postoperative+Pain"
  [15]=>
  string(19) "2019-05-01 08:05:50"
  ["add_date"]=>
  string(19) "2019-05-01 08:05:50"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-23 14:18:27"
  ["create_at"]=>
  string(19) "2019-05-23 14:18:27"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Heron Therapeutics Receives Complete Response Letter For HTX-011 For The Management Of Pos

SAN DIEGO, May 1, 2019 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company

array(40) {
  [0]=>
  string(4) "1907"
  ["article_id"]=>
  string(4) "1907"
  [1]=>
  string(157) "Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance"
  ["article_title"]=>
  string(157) "Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance"
  [2]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy May 1, 2019 -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one l"
  ["short_description"]=>
  string(150) "Audience: Consumer, Health Professional, Pharmacy May 1, 2019 -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one l"
  [3]=>
  string(251) "Audience: Consumer, Health Professional, Pharmacy May 1, 2019 -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL). This product was manufactured..."
  ["description"]=>
  string(251) "Audience: Consumer, Health Professional, Pharmacy May 1, 2019 -- Sagent Pharmaceuticals, Inc. today announced the voluntary nationwide recall of one lot of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL). This product was manufactured..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "7"
  ["rss_id"]=>
  string(1) "7"
  [14]=>
  string(300) "https://www.drugs.com/fda/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-ketorolac-tromethamine-usp-60mg-2ml-30mg-14267.html?utm_source=ddc&utm_medium=rss&utm_campaign=Sagent+Pharmaceuticals+Issues+Voluntary+Nationwide+Recall+of+Ketorolac+Tromethamine+Injection%2C+USP%2C+60mg%2F2mL+%2830m"
  ["blog_url"]=>
  string(300) "https://www.drugs.com/fda/sagent-pharmaceuticals-issues-voluntary-nationwide-recall-ketorolac-tromethamine-usp-60mg-2ml-30mg-14267.html?utm_source=ddc&utm_medium=rss&utm_campaign=Sagent+Pharmaceuticals+Issues+Voluntary+Nationwide+Recall+of+Ketorolac+Tromethamine+Injection%2C+USP%2C+60mg%2F2mL+%2830m"
  [15]=>
  string(19) "2019-05-01 08:00:00"
  ["add_date"]=>
  string(19) "2019-05-01 08:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:50"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Inject

Audience: Consumer, Health Professional, Pharmacy May 1, 2019 -- Sagent Pharmaceuticals, Inc. today announced the volunt

array(40) {
  [0]=>
  string(4) "1962"
  ["article_id"]=>
  string(4) "1962"
  [1]=>
  string(54) "Police launch fourth investigation into Gosport deaths"
  ["article_title"]=>
  string(54) "Police launch fourth investigation into Gosport deaths"
  [2]=>
  string(132) "The police have launched a fourth investigation into the 450 deaths that occurred at Gosport Memorial Hospital over nearly 15 years."
  ["short_description"]=>
  string(132) "The police have launched a fourth investigation into the 450 deaths that occurred at Gosport Memorial Hospital over nearly 15 years."
  [3]=>
  string(132) "The police have launched a fourth investigation into the 450 deaths that occurred at Gosport Memorial Hospital over nearly 15 years."
  ["description"]=>
  string(132) "The police have launched a fourth investigation into the 450 deaths that occurred at Gosport Memorial Hospital over nearly 15 years."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(142) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/police-launch-fourth-investigation-into-gosport-deaths/20206491.article"
  ["blog_url"]=>
  string(142) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/police-launch-fourth-investigation-into-gosport-deaths/20206491.article"
  [15]=>
  string(19) "2019-05-01 00:58:00"
  ["add_date"]=>
  string(19) "2019-05-01 00:58:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Police launch fourth investigation into Gosport deaths

The police have launched a fourth investigation into the 450 deaths that occurred at Gosport Memorial Hospital over near

array(40) {
  [0]=>
  string(4) "1963"
  ["article_id"]=>
  string(4) "1963"
  [1]=>
  string(86) "Pharmacist-led oral health intervention scheme to be rolled out after successful pilot"
  ["article_title"]=>
  string(86) "Pharmacist-led oral health intervention scheme to be rolled out after successful pilot"
  [2]=>
  string(152) "A pilot programme in which pharmacists offer oral health advice to patients while they wait for prescriptions is due to be rolled out across the nort"
  ["short_description"]=>
  string(152) "A pilot programme in which pharmacists offer oral health advice to patients while they wait for prescriptions is due to be rolled out across the nort"
  [3]=>
  string(170) "A pilot programme in which pharmacists offer oral health advice to patients while they wait for prescriptions is due to be rolled out across the north east of England."
  ["description"]=>
  string(170) "A pilot programme in which pharmacists offer oral health advice to patients while they wait for prescriptions is due to be rolled out across the north east of England."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(165) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacist-led-oral-health-intervention-scheme-to-be-rolled-out-after-successful-pilot/20206461.article"
  ["blog_url"]=>
  string(165) "https://www.pharmaceutical-journal.com/news-and-analysis/news/pharmacist-led-oral-health-intervention-scheme-to-be-rolled-out-after-successful-pilot/20206461.article"
  [15]=>
  string(19) "2019-05-01 00:37:00"
  ["add_date"]=>
  string(19) "2019-05-01 00:37:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Pharmacist-led oral health intervention scheme to be rolled out after successful pilot

A pilot programme in which pharmacists offer oral health advice to patients while they wait for prescriptions is due to

array(40) {
  [0]=>
  string(4) "2211"
  ["article_id"]=>
  string(4) "2211"
  [1]=>
  string(108) "I’m embarrassed by the problems my new staff member is uncovering — and keep getting defensive"
  ["article_title"]=>
  string(108) "I’m embarrassed by the problems my new staff member is uncovering — and keep getting defensive"
  [2]=>
  string(166) "A reader writes: I’m the problem and I don’t know how to stop. I’m the executive director of a small (8 staff) but old nonprofit (40+ years). Iâ"
  ["short_description"]=>
  string(166) "A reader writes: I’m the problem and I don’t know how to stop. I’m the executive director of a small (8 staff) but old nonprofit (40+ years). Iâ"
  [3]=>
  string(1603) "

A reader writes: I’m the problem and I don’t know how to stop. I’m the executive director of a small (8 staff) but old nonprofit (40+ years). I’ve been the ED for eight years and most of the staff have been with me for five or more years. A year ago, we hired a new […]

&#nl&#nl

I’m embarrassed by the problems my new staff member is uncovering — and keep getting defensive was originally published by Alison Green on Ask a Manager.

&#nl" ["description"]=> string(1603) "

A reader writes: I’m the problem and I don’t know how to stop. I’m the executive director of a small (8 staff) but old nonprofit (40+ years). I’ve been the ED for eight years and most of the staff have been with me for five or more years. A year ago, we hired a new […]

&#nl&#nl

I’m embarrassed by the problems my new staff member is uncovering — and keep getting defensive was originally published by Alison Green on Ask a Manager.

&#nl" [4]=> NULL ["image"]=> NULL [5]=> NULL ["big_image"]=> NULL [6]=> NULL ["feature_images"]=> NULL [7]=> NULL ["employer_id"]=> NULL [8]=> string(1) "5" ["category"]=> string(1) "5" [9]=> string(3) "RSS" ["added_by"]=> string(3) "RSS" [10]=> string(2) "10" ["status"]=> string(2) "10" [11]=> NULL ["highlight_status"]=> NULL [12]=> NULL ["hit_count"]=> NULL [13]=> string(2) "50" ["rss_id"]=> string(2) "50" [14]=> string(132) "https://www.askamanager.org/2019/04/im-embarrassed-by-the-problems-my-new-staff-member-is-uncovering-and-keep-getting-defensive.html" ["blog_url"]=> string(132) "https://www.askamanager.org/2019/04/im-embarrassed-by-the-problems-my-new-staff-member-is-uncovering-and-keep-getting-defensive.html" [15]=> string(19) "2019-04-30 22:59:18" ["add_date"]=> string(19) "2019-04-30 22:59:18" [16]=> NULL ["bythe"]=> NULL [17]=> NULL ["timestamp"]=> NULL [18]=> string(19) "2019-05-09 16:41:44" ["create_at"]=> string(19) "2019-05-09 16:41:44" [19]=> string(0) "" ["slug"]=> string(0) "" }

I’m embarrassed by the problems my new staff member is uncovering — and keep

A reader writes: I’m the problem and I don’t know how to stop. I’m the executive director of a s

array(40) {
  [0]=>
  string(4) "2204"
  ["article_id"]=>
  string(4) "2204"
  [1]=>
  string(67) "EPSI and George Clinical to partner to expand Asia-Pacific presence"
  ["article_title"]=>
  string(67) "EPSI and George Clinical to partner to expand Asia-Pacific presence"
  [2]=>
  string(124) "EPSI and George Clinical enter a strategic partnership to deliver clinical trial management services to clients in Asia-Pac."
  ["short_description"]=>
  string(124) "EPSI and George Clinical enter a strategic partnership to deliver clinical trial management services to clients in Asia-Pac."
  [3]=>
  string(124) "EPSI and George Clinical enter a strategic partnership to deliver clinical trial management services to clients in Asia-Pac."
  ["description"]=>
  string(124) "EPSI and George Clinical enter a strategic partnership to deliver clinical trial management services to clients in Asia-Pac."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(173) "https://www.outsourcing-pharma.com/Article/2019/04/30/EPSI-and-George-Clinical-to-partner-to-expand-Asia-Pacific-presence?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(173) "https://www.outsourcing-pharma.com/Article/2019/04/30/EPSI-and-George-Clinical-to-partner-to-expand-Asia-Pacific-presence?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-04-30 22:55:00"
  ["add_date"]=>
  string(19) "2019-04-30 22:55:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

EPSI and George Clinical to partner to expand Asia-Pacific presence

EPSI and George Clinical enter a strategic partnership to deliver clinical trial management services to clients in Asia-

array(40) {
  [0]=>
  string(4) "2422"
  ["article_id"]=>
  string(4) "2422"
  [1]=>
  string(74) "Allergan creates 63 jobs with biologics manufacturing expansion in Ireland"
  ["article_title"]=>
  string(74) "Allergan creates 63 jobs with biologics manufacturing expansion in Ireland"
  [2]=>
  string(152) "Allergan will expand its existing facilities in Ireland through an investment of â65m to produce new product formats for existing and investigational"
  ["short_description"]=>
  string(152) "Allergan will expand its existing facilities in Ireland through an investment of â65m to produce new product formats for existing and investigational"
  [3]=>
  string(162) "Allergan will expand its existing facilities in Ireland through an investment of â65m to produce new product formats for existing and investigational products."
  ["description"]=>
  string(162) "Allergan will expand its existing facilities in Ireland through an investment of â65m to produce new product formats for existing and investigational products."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(3) "107"
  ["rss_id"]=>
  string(3) "107"
  [14]=>
  string(146) "https://www.biopharma-reporter.com/Article/2019/04/30/Allergan-invests-in-biologics-in-Ireland?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(146) "https://www.biopharma-reporter.com/Article/2019/04/30/Allergan-invests-in-biologics-in-Ireland?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-04-30 22:40:00"
  ["add_date"]=>
  string(19) "2019-04-30 22:40:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:36"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:36"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Allergan creates 63 jobs with biologics manufacturing expansion in Ireland

Allergan will expand its existing facilities in Ireland through an investment of â65m to produce new product formats

array(40) {
  [0]=>
  string(4) "2205"
  ["article_id"]=>
  string(4) "2205"
  [1]=>
  string(96) "'Not a minor misdemeanor': New report finds more than 80% of trials are still unreported"
  ["article_title"]=>
  string(96) "'Not a minor misdemeanor': New report finds more than 80% of trials are still unreported"
  [2]=>
  string(152) "An international coalition of health integrity groups today demands that European universities must make clinical trial results public â with 83% all"
  ["short_description"]=>
  string(152) "An international coalition of health integrity groups today demands that European universities must make clinical trial results public â with 83% all"
  [3]=>
  string(211) "An international coalition of health integrity groups today demands that European universities must make clinical trial results public â with 83% all of due trials still unreported, according to a new report."
  ["description"]=>
  string(211) "An international coalition of health integrity groups today demands that European universities must make clinical trial results public â with 83% all of due trials still unreported, according to a new report."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(190) "https://www.outsourcing-pharma.com/Article/2019/04/30/Not-a-minor-misdemeanor-New-report-finds-more-than-80-of-trials-are-still-unreported?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(190) "https://www.outsourcing-pharma.com/Article/2019/04/30/Not-a-minor-misdemeanor-New-report-finds-more-than-80-of-trials-are-still-unreported?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-04-30 22:40:00"
  ["add_date"]=>
  string(19) "2019-04-30 22:40:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

'Not a minor misdemeanor': New report finds more than 80% of trials are still unre

An international coalition of health integrity groups today demands that European universities must make clinical trial

array(40) {
  [0]=>
  string(4) "2160"
  ["article_id"]=>
  string(4) "2160"
  [1]=>
  string(81) "Healthtech company partners with academic health science networks for Medica 2019"
  ["article_title"]=>
  string(81) "Healthtech company partners with academic health science networks for Medica 2019"
  [2]=>
  string(154) "The Academic Health Science Networks (AHSNs) will be joining the Association of British HealthTech Industries’ (ABHI) for the first time at Medica."
  ["short_description"]=>
  string(154) "The Academic Health Science Networks (AHSNs) will be joining the Association of British HealthTech Industries’ (ABHI) for the first time at Medica."
  [3]=>
  string(154) "The Academic Health Science Networks (AHSNs) will be joining the Association of British HealthTech Industries’ (ABHI) for the first time at Medica."
  ["description"]=>
  string(154) "The Academic Health Science Networks (AHSNs) will be joining the Association of British HealthTech Industries’ (ABHI) for the first time at Medica."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/healthtech-company-partners-with-the-academic-health-science/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/healthtech-company-partners-with-the-academic-health-science/"
  [15]=>
  string(19) "2019-04-30 22:03:51"
  ["add_date"]=>
  string(19) "2019-04-30 22:03:51"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:39"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Healthtech company partners with academic health science networks for Medica 2019

The Academic Health Science Networks (AHSNs) will be joining the Association of British HealthTech Industries’ (A

array(40) {
  [0]=>
  string(4) "2161"
  ["article_id"]=>
  string(4) "2161"
  [1]=>
  string(85) "Axial3D announces webinar which will focus on the impact of 3D printing in healthcare"
  ["article_title"]=>
  string(85) "Axial3D announces webinar which will focus on the impact of 3D printing in healthcare"
  [2]=>
  string(124) "Following the success of the original session at SXSW, axial3D is running a webinar on the operation and use of 3D printing."
  ["short_description"]=>
  string(124) "Following the success of the original session at SXSW, axial3D is running a webinar on the operation and use of 3D printing."
  [3]=>
  string(124) "Following the success of the original session at SXSW, axial3D is running a webinar on the operation and use of 3D printing."
  ["description"]=>
  string(124) "Following the success of the original session at SXSW, axial3D is running a webinar on the operation and use of 3D printing."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(102) "https://www.medicalplasticsnews.com/news/axial3d-announces-webinar-which-will-focus-on-the-impact-of-/"
  ["blog_url"]=>
  string(102) "https://www.medicalplasticsnews.com/news/axial3d-announces-webinar-which-will-focus-on-the-impact-of-/"
  [15]=>
  string(19) "2019-04-30 22:00:00"
  ["add_date"]=>
  string(19) "2019-04-30 22:00:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:39"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:39"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Axial3D announces webinar which will focus on the impact of 3D printing in healthcare

Following the success of the original session at SXSW, axial3D is running a webinar on the operation and use of 3D print

array(40) {
  [0]=>
  string(4) "1964"
  ["article_id"]=>
  string(4) "1964"
  [1]=>
  string(84) "MHRA issues drug alert for prednisolone tablets after dosage mislabelling in Braille"
  ["article_title"]=>
  string(84) "MHRA issues drug alert for prednisolone tablets after dosage mislabelling in Braille"
  [2]=>
  string(154) "The Medicines and Healthcare products Regulatory Agency has issued a warning not to supply prednisolone from five batches of 5mg tablets to patients"
  ["short_description"]=>
  string(154) "The Medicines and Healthcare products Regulatory Agency has issued a warning not to supply prednisolone from five batches of 5mg tablets to patients"
  [3]=>
  string(221) "The Medicines and Healthcare products Regulatory Agency has issued a warning not to supply prednisolone from five batches of 5mg tablets to patients with sight problems following a Braille misprint on the packaging."
  ["description"]=>
  string(221) "The Medicines and Healthcare products Regulatory Agency has issued a warning not to supply prednisolone from five batches of 5mg tablets to patients with sight problems following a Braille misprint on the packaging."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(172) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/mhra-issues-drug-alert-for-prednisolone-tablets-after-dosage-mislabelling-in-braille/20206482.article"
  ["blog_url"]=>
  string(172) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/mhra-issues-drug-alert-for-prednisolone-tablets-after-dosage-mislabelling-in-braille/20206482.article"
  [15]=>
  string(19) "2019-04-30 20:46:00"
  ["add_date"]=>
  string(19) "2019-04-30 20:46:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

MHRA issues drug alert for prednisolone tablets after dosage mislabelling in Braille

The Medicines and Healthcare products Regulatory Agency has issued a warning not to supply prednisolone from five bat

array(40) {
  [0]=>
  string(4) "2107"
  ["article_id"]=>
  string(4) "2107"
  [1]=>
  string(128) "Social media influencers unfit for weight management advice: ‘Misinformation can undermine public health campaigns’"
  ["article_title"]=>
  string(128) "Social media influencers unfit for weight management advice: ‘Misinformation can undermine public health campaigns’"
  [2]=>
  string(122) "Researchers warns that social media influencers with weight management blogs may not offer credible or trustworthy advice."
  ["short_description"]=>
  string(122) "Researchers warns that social media influencers with weight management blogs may not offer credible or trustworthy advice."
  [3]=>
  string(122) "Researchers warns that social media influencers with weight management blogs may not offer credible or trustworthy advice."
  ["description"]=>
  string(122) "Researchers warns that social media influencers with weight management blogs may not offer credible or trustworthy advice."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(213) "https://www.foodnavigator.com/Article/2019/04/30/Social-media-influencers-unfit-for-weight-management-advice-Misinformation-can-undermine-public-health-campaigns?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(213) "https://www.foodnavigator.com/Article/2019/04/30/Social-media-influencers-unfit-for-weight-management-advice-Misinformation-can-undermine-public-health-campaigns?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-04-30 20:44:00"
  ["add_date"]=>
  string(19) "2019-04-30 20:44:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:32"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Social media influencers unfit for weight management advice: ‘Misinformation can und

Researchers warns that social media influencers with weight management blogs may not offer credible or trustworthy advic